Literature DB >> 31733491

Heterogeneity in tumours: Validating the use of radiomic features on 18F-FDG PET/CT scans of lung cancer patients as a prognostic tool.

Marie Manon Krebs Krarup1, Lotte Nygård2, Ivan Richter Vogelius3, Flemming Littrup Andersen4, Gary Cook5, Vicky Goh6, Barbara Malene Fischer7.   

Abstract

AIM: The aim was to validate promising radiomic features (RFs)1 on 18F-flourodeoxyglucose positron emission tomography/computed tomography-scans (18F-FDG PET/CT) of non-small cell lung cancer (NSCLC) patients undergoing definitive chemo-radiotherapy.
METHODS: 18F-FDG PET/CT scans performed for radiotherapy (RT) planning were retrieved. Auto-segmentation with visual adaption was used to define the primary tumour on PET images. Six pre-selected prognostic and reproducible PET texture -and shape-features were calculated using texture respectively shape analysis. The correlation between these RFs and metabolic active tumour volume (MTV)3, gross tumour volume (GTV)4 and maximum and mean of standardized uptake value (SUV)5 was tested with a Spearman's Rank test. The prognostic value of RFs was tested in a univariate cox regression analysis and a multivariate cox regression analysis with GTV, clinical stage and histology. P-value ≤ 0.05 were considered significant.
RESULTS: Image analysis was performed for 233 patients: 145 males and 88 females, mean age of 65.7 and clinical stage II-IV. Mean GTV was 129.87 cm3 (SD 130.30 cm3). Texture and shape-features correlated more strongly to MTV and GTV compared to SUV-measurements. Four RFs predicted PFS in the univariate analysis. No RFs predicted PFS in the multivariate analysis, whereas GTV and clinical stage predicted PFS (p = 0.001 and p = 0.008 respectively).
CONCLUSION: The pre-selected RFs were insignificant in predicting PFS in combination with GTV, clinical stage and histology. These results might be due to variations in technical parameters. However, it is relevant to question whether RFs are stable enough to provide clinically useful information.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carcinoma, Non Small Cell Lung; Heterogeneity; Positron Emission Tomography Computed Tomography; Prognosis; Radiomics; Texture features

Mesh:

Substances:

Year:  2019        PMID: 31733491     DOI: 10.1016/j.radonc.2019.10.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [18F]FDG PET/CT imaging: quantitative analysis of [18F]FDG uptake in primary tumors and metastatic lymph nodes.

Authors:  DaQuan Wang; Xu Zhang; Bo Qiu; SongRan Liu; Hui Liu; ChaoJie Zheng; Jia Fu; YiWen Mo; NaiBin Chen; Rui Zhou; Chu Chu; FangJie Liu; JinYu Guo; Yin Zhou; Yun Zhou; Wei Fan; Hui Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-11       Impact factor: 10.057

Review 2.  Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.

Authors:  David Morland; Elizabeth Katherine Anna Triumbari; Luca Boldrini; Roberto Gatta; Daniele Pizzuto; Salvatore Annunziata
Journal:  Diagnostics (Basel)       Date:  2022-05-27

3.  Magnetic resonance imaging-derived radiomic signature predicts locoregional failure after organ preservation therapy in patients with hypopharyngeal squamous cell carcinoma.

Authors:  Che-Yu Hsu; Shih-Min Lin; Ngan Ming Tsang; Yu-Hsiang Juan; Chun-Wei Wang; Wei-Chung Wang; Sung-Hsin Kuo
Journal:  Clin Transl Radiat Oncol       Date:  2020-08-31

4.  Development and Validation of a 18F-FDG PET-Based Radiomic Model for Evaluating Hypermetabolic Mediastinal-Hilar Lymph Nodes in Non-Small-Cell Lung Cancer.

Authors:  Ming-Li Ouyang; Yi-Ran Wang; Qing-Shan Deng; Ye-Fei Zhu; Zhen-Hua Zhao; Ling Wang; Liang-Xing Wang; Kun Tang
Journal:  Front Oncol       Date:  2021-09-08       Impact factor: 6.244

5.  Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [18F]FDG PET/CT in Early Triple-Negative Breast Cancer.

Authors:  Clément Bouron; Clara Mathie; Valérie Seegers; Olivier Morel; Pascal Jézéquel; Hamza Lasla; Camille Guillerminet; Sylvie Girault; Marie Lacombe; Avigaelle Sher; Franck Lacoeuille; Anne Patsouris; Aude Testard
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

Review 6.  Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential.

Authors:  Xingping Zhang; Yanchun Zhang; Guijuan Zhang; Xingting Qiu; Wenjun Tan; Xiaoxia Yin; Liefa Liao
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244

7.  Combination of 18F-Fluorodeoxyglucose PET/CT Radiomics and Clinical Features for Predicting Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.

Authors:  Shen Li; Yadi Li; Min Zhao; Pengyuan Wang; Jun Xin
Journal:  Korean J Radiol       Date:  2022-09       Impact factor: 7.109

8.  Towards guidelines to harmonize textural features in PET: Haralick textural features vary with image noise, but exposure-invariant domains enable comparable PET radiomics.

Authors:  George Amadeus Prenosil; Thilo Weitzel; Markus Fürstner; Michael Hentschel; Thomas Krause; Paul Cumming; Axel Rominger; Bernd Klaeser
Journal:  PLoS One       Date:  2020-03-16       Impact factor: 3.240

9.  Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.

Authors:  Nasha Zhang; Rachel Liang; Michael F Gensheimer; Meiying Guo; Hui Zhu; Jinming Yu; Maximilian Diehn; Bill W Loo; Ruijiang Li; Jia Wu
Journal:  Theranostics       Date:  2020-09-23       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.